secwatch.observer — SEC 8-K summary
======================================

Issuer:     Carisma Therapeutics Inc. (CARM)
CIK:        0001485003
Form:       8-K
Filed at:   2022-12-29T23:59:59+00:00
Accession:  0001485003-22-000182
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sesen Bio Amends Merger with Carisma: Special Dividend Raised to ~$70M, CVR Expanded
--------------------------------------------------------------------------------

- Expected special cash dividend increased from up to $25M to ~$70M ($0.34/share); up from ~$0.12.
- Minimum net cash at closing reduced from $100M to $75M; CVR now includes proceeds from Vicineum and other assets.
- Merger expected to close Q1 2023; Carisma's ~$30M financing remains committed and concurrent.
- Activist Investor Group (Radoff/Torok, 7.4% stake) continues to demand $100M dividend; company offered $70M.
- Post-merger Sesen stockholders expected to own 25.2% of combined company under exchange ratio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1485003/000148500322000182/0001485003-22-000182-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1485003/000148500322000182/sesn-20221229.htm
  HTML page:      https://secwatch.observer/filing/0001485003-22-000182

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer